TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Urologix AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
587
|
713 | |
| Financial expenses |
0
|
0 | |
| Earnings before taxes |
143
|
188 | |
| EBITDA |
154
|
192 | |
| Total assets |
178
|
224 | |
| Current assets |
104
|
203 | |
| Current liabilities |
44
|
54 | |
| Equity capital |
134
|
170 | |
| - share capital |
8
|
9 | |
| Employees (average) |
4
|
5
|
5 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
75.3%
|
75.9% | |
| Turnover per employee |
117
|
143 | |
| Profit as a percentage of turnover |
24.4%
|
26.4% | |
| Return on assets (ROA) |
80.3%
|
83.9% | |
| Current ratio |
236.4%
|
375.9% | |
| Return on equity (ROE) |
106.7%
|
110.6% | |
| Change turnover |
-56
|
48 | |
| Change turnover % |
0%
|
-9%
|
7% |
| Chg. No. of employees |
-1
|
0
|
0 |
| Chg. No. of employees % |
-20%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.